SBIO Holdings Information

SBIO is an equity ETF with a total of 105 individual holdings. The top holdings are CG Oncology stock at 3.65%, Travere Therapeutics at 3.37%, Dianthus Therapeutics at 3.28%, Xenon Pharmaceuticals at 3.20%, and Oruka Therapeutics at 3.10%.

Total Holdings

105

Top 10 Percentage

28.71%

Asset Class

Equity

ETF Category

Health

Assets

240.42M

PE Ratio

n/a

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	CGON	CG Oncology, Inc.	3.65%	121,532
2	TVTX	Travere Therapeutics, Inc.	3.37%	128,099
3	DNTH	Dianthus Therapeutics, Inc.	3.28%	75,288
4	XENE	Xenon Pharmaceuticals Inc.	3.20%	133,153
5	ORKA	Oruka Therapeutics, Inc.	3.10%	83,137
6	ACAD	ACADIA Pharmaceuticals Inc.	2.66%	235,932
7	EWTX	Edgewise Therapeutics, Inc.	2.57%	148,274
8	DFTX	Definium Therapeutics, Inc.	2.30%	150,244
9	RLAY	Relay Therapeutics, Inc.	2.30%	300,243
10	MANE	Veradermics, Incorporated	2.28%	57,590
11	DYN	Dyne Therapeutics, Inc.	2.23%	227,737
12	TARS	Tarsus Pharmaceuticals, Inc.	2.17%	59,248
13	AMLX	Amylyx Pharmaceuticals, Inc.	2.10%	153,131
14	DNLI	Denali Therapeutics Inc.	1.96%	218,682
15	IDYA	IDEAYA Biosciences, Inc.	1.94%	120,999
16	GPCR	Structure Therapeutics Inc.	1.87%	97,953
17	CLDX	Celldex Therapeutics, Inc.	1.73%	108,148
18	IMNM	Immunome, Inc.	1.68%	156,038
19	IRON	Disc Medicine, Inc.	1.68%	52,644
20	NAMS	NewAmsterdam Pharma Company N.V.	1.65%	161,062
21	MBX	MBX Biosciences, Inc.	1.63%	65,544
22	ZLAB	Zai Lab Limited	1.59%	150,545
23	SLS	SELLAS Life Sciences Group, Inc.	1.43%	256,257
24	VERA	Vera Therapeutics, Inc.	1.43%	98,863
25	BCRX	BioCryst Pharmaceuticals, Inc.	1.40%	350,197

Showing 25 of 105 holdings

Subscribe to see the full list

Activate Now

As of Sep 4, 2026